Patients' Participation in Clinical Ethics: A Vicarious Voice

Area of Science:

• Bioethics
• Comparative Health Law
• Medical Ethics

Background:

• Patient autonomy is a cornerstone of healthcare, yet incapacitated patients cannot directly participate in clinical ethics decisions.
• In the US, legal surrogates (like Durable Power of Attorney) often make decisions for incapacitated patients.
• European countries typically place decision-making authority with physicians for incapacitated patients, despite recognizing advance directives and trusted persons.

Purpose of the Study:

• To explore contrasting cultural differences in surrogate decision-making for incapacitated patients.
• To analyze the legitimacy of surrogates versus physicians in speaking for patients unable to voice preferences.
• To understand how differing bioethical frameworks (autonomy vs. public health) shape clinical ethics support.

Main Methods:

• Comparative analysis of legal and ethical frameworks in the US and European countries.
• Examination of the roles and authority of patient representatives in clinical ethics.
• Review of cultural underpinnings influencing decision-making for incapacitated patients.

Main Results:

• US surrogates, often family, have decision-making authority due to bearing decision burdens.
• European physicians generally hold decision-making authority, with surrogates being primarily consulted.
• Cultural differences stem from autonomy-focused bioethics (US) versus public health ethics (Europe).

Conclusions:

• The US model empowers surrogates, reflecting an individualistic, autonomy-centric approach.
• The European model prioritizes collective well-being and physician-led decisions for incapacitated patients.
• Understanding these frameworks is crucial for interpreting differences in clinical ethics support globally.